Frisium



Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 100.0%
Loss Of Consciousness 100.0%
Secondary
Epilepsy 32.9%
Product Used For Unknown Indication 9.0%
Supraventricular Tachycardia 6.1%
Chronic Obstructive Pulmonary Disease 5.2%
Dermatitis 5.2%
Drug Use For Unknown Indication 4.8%
Maternal Exposure Timing Unspecified 3.8%
Grand Mal Convulsion 3.6%
Rash 3.6%
Thrombosis Prophylaxis 3.6%
Convulsion 3.1%
Sleep Disorder 3.1%
Tachycardia Paroxysmal 3.1%
Drug Exposure During Pregnancy 2.6%
Hypothyroidism 2.1%
Conjunctivitis 1.7%
Nausea 1.7%
Pruritus 1.7%
Prophylaxis Of Neural Tube Defect 1.6%
Vomiting 1.4%
Toxic Epidermal Necrolysis 13.7%
Spina Bifida 12.3%
Suicide Attempt 11.0%
Ventricular Septal Defect 8.2%
Weight Decreased 6.8%
Epilepsy 5.5%
Product Quality Issue 5.5%
Convulsion 4.1%
Maternal Drugs Affecting Foetus 4.1%
Weight Increased 4.1%
Drug Exposure During Pregnancy 2.7%
Exposure During Pregnancy 2.7%
Multiple Drug Overdose Intentional 2.7%
Restlessness 2.7%
Speech Disorder 2.7%
Stevens-johnson Syndrome 2.7%
Thrombocytopenia 2.7%
Wrong Drug Administered 2.7%
Amenorrhoea 1.4%
Cardiac Aneurysm 1.4%
Concomitant
Epilepsy 49.2%
Product Used For Unknown Indication 9.4%
Drug Use For Unknown Indication 9.0%
Convulsion 7.1%
Prophylaxis 3.0%
Glioblastoma 2.7%
Premedication 2.7%
Depression 2.5%
Partial Seizures 2.0%
Infection 1.9%
Acute Myeloid Leukaemia 1.4%
Anxiety 1.2%
Grand Mal Convulsion 1.2%
Status Epilepticus 1.1%
Autoimmune Thrombocytopenia 1.0%
Hypothyroidism 1.0%
Hypertension 0.9%
Hypokalaemia 0.8%
Multiple Sclerosis 0.8%
Systemic Lupus Erythematosus 0.8%
Somnolence 9.4%
Status Epilepticus 8.7%
Vomiting 8.7%
Weight Decreased 6.3%
Convulsion 5.5%
Pyrexia 5.5%
Transaminases Increased 5.5%
Urinary Tract Infection 5.5%
Pregnancy 4.7%
Restlessness 4.7%
Disease Progression 3.9%
Encephalopathy 3.9%
Epilepsy 3.9%
Fatigue 3.9%
Weight Increased 3.9%
Fall 3.1%
Hepatic Cirrhosis 3.1%
Malaise 3.1%
Partial Seizures 3.1%
Rash 3.1%